Skip to main content
Caplight Logo









Orio Therapeutics SA

Orio Therapeutics SA

Private
MontheyHealthcare & Life Scienceshttps://oriotx.com/

Last Round

Grant

Jun 3, 2024

Total Funding Raised

$720,000

Company Overview

Orio Therapeutics SA is a biotechnology company developing regenerative drugs using protein engineering and targeted drug-delivery technologies, with an initial focus on a cardioprotective therapy for heart attack patients.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

protein engineeringdrug delivery platformregenerative medicinecardioprotective drugregen medtargeted drug deliverymyocardial infarction therapybiologics developmenttherapeutic proteinspre-clinical biotechdrug licensingdrug co-development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Orio Therapeutics SA Comparables

Compare Orio Therapeutics SA with similar companies based on industry and business-model similarity.

Orio Therapeutics SA comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Regencor
79%
TargaCell Corporation
76%
AI Proteins
63%

Orio Therapeutics SA Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 3, 2024
Pre SeedApr 4, 2024

Key People

Founding team and executive leadership

Ziad Julier

Co-founder And CEO

Founding Team

Orio Therapeutics SA Investors

Notable investors and investment history

Orio Therapeutics SA investors
InvestorRounds
Venture KickGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 15, 2026

    Monthly visitors increased 74% MoM, reaching 3.2K.

  • May 2, 2025

    Monthly visitors increased 156% MoM, reaching 1.7K.

Orio Therapeutics SA Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Orio Therapeutics SA Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Orio Therapeutics SA's valuation, stock price, and market status.

Firmographic Details

HeadquartersMonthey
Employee Range3
Year Founded2023
Last FundingJun 3, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?